Yusuke Nakamura to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Yusuke Nakamura has written about Antineoplastic Agents, Immunological.
Connection Strength
0.171
-
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC Cancer. 2018 Jun 08; 18(1):646.
Score: 0.137
-
The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. PLoS One. 2018; 13(8):e0202272.
Score: 0.035